PMC:7386785 / 95452-96193 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T414","span":{"begin":298,"end":306},"obj":"Disease"},{"id":"T415","span":{"begin":504,"end":508},"obj":"Disease"},{"id":"T416","span":{"begin":711,"end":719},"obj":"Disease"}],"attributes":[{"id":"A414","pred":"mondo_id","subj":"T414","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A415","pred":"mondo_id","subj":"T415","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A416","pred":"mondo_id","subj":"T416","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Facility cases: among clinically suspected patients: those with a positive RT‐PCRFacility controls: clinically non‐suspected patients + suspected patients with negative RT‐PCRCountry: ChinaDates: 14 January 2020‐9 February 2020Symptoms and severity: all patients admitted, with exposure history to COVID‐19, so all levels of severity; days from illness onset until admission (median, IQR): 2.0 (1.0‐5.0); patient population with general mild disease and limited presence of comorbidities (range 0%‐2.3% (COPD))Demographics: age: controls median 40.0 years (IQR 32.5‐54.5), cases median 39.0 years (IQR 37.0‐41.5)M%/F%: cases 71.4/28.6, controls 63.2/36.8Exposure history: epidemiological history of exposure to COVID‐19 (as per WHO guidance)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T632","span":{"begin":64,"end":65},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Facility cases: among clinically suspected patients: those with a positive RT‐PCRFacility controls: clinically non‐suspected patients + suspected patients with negative RT‐PCRCountry: ChinaDates: 14 January 2020‐9 February 2020Symptoms and severity: all patients admitted, with exposure history to COVID‐19, so all levels of severity; days from illness onset until admission (median, IQR): 2.0 (1.0‐5.0); patient population with general mild disease and limited presence of comorbidities (range 0%‐2.3% (COPD))Demographics: age: controls median 40.0 years (IQR 32.5‐54.5), cases median 39.0 years (IQR 37.0‐41.5)M%/F%: cases 71.4/28.6, controls 63.2/36.8Exposure history: epidemiological history of exposure to COVID‐19 (as per WHO guidance)"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T323","span":{"begin":504,"end":508},"obj":"Phenotype"}],"attributes":[{"id":"A323","pred":"hp_id","subj":"T323","obj":"http://purl.obolibrary.org/obo/HP_0006510"}],"text":"Facility cases: among clinically suspected patients: those with a positive RT‐PCRFacility controls: clinically non‐suspected patients + suspected patients with negative RT‐PCRCountry: ChinaDates: 14 January 2020‐9 February 2020Symptoms and severity: all patients admitted, with exposure history to COVID‐19, so all levels of severity; days from illness onset until admission (median, IQR): 2.0 (1.0‐5.0); patient population with general mild disease and limited presence of comorbidities (range 0%‐2.3% (COPD))Demographics: age: controls median 40.0 years (IQR 32.5‐54.5), cases median 39.0 years (IQR 37.0‐41.5)M%/F%: cases 71.4/28.6, controls 63.2/36.8Exposure history: epidemiological history of exposure to COVID‐19 (as per WHO guidance)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1018","span":{"begin":184,"end":195},"obj":"Sentence"},{"id":"T1019","span":{"begin":196,"end":389},"obj":"Sentence"},{"id":"T1020","span":{"begin":390,"end":741},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Facility cases: among clinically suspected patients: those with a positive RT‐PCRFacility controls: clinically non‐suspected patients + suspected patients with negative RT‐PCRCountry: ChinaDates: 14 January 2020‐9 February 2020Symptoms and severity: all patients admitted, with exposure history to COVID‐19, so all levels of severity; days from illness onset until admission (median, IQR): 2.0 (1.0‐5.0); patient population with general mild disease and limited presence of comorbidities (range 0%‐2.3% (COPD))Demographics: age: controls median 40.0 years (IQR 32.5‐54.5), cases median 39.0 years (IQR 37.0‐41.5)M%/F%: cases 71.4/28.6, controls 63.2/36.8Exposure history: epidemiological history of exposure to COVID‐19 (as per WHO guidance)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1763","span":{"begin":43,"end":51},"obj":"Species"},{"id":"1764","span":{"begin":125,"end":133},"obj":"Species"},{"id":"1765","span":{"begin":146,"end":154},"obj":"Species"},{"id":"1766","span":{"begin":254,"end":262},"obj":"Species"},{"id":"1767","span":{"begin":405,"end":412},"obj":"Species"},{"id":"1779","span":{"begin":298,"end":306},"obj":"Disease"},{"id":"1780","span":{"begin":504,"end":508},"obj":"Disease"},{"id":"1781","span":{"begin":711,"end":719},"obj":"Disease"}],"attributes":[{"id":"A1763","pred":"tao:has_database_id","subj":"1763","obj":"Tax:9606"},{"id":"A1764","pred":"tao:has_database_id","subj":"1764","obj":"Tax:9606"},{"id":"A1765","pred":"tao:has_database_id","subj":"1765","obj":"Tax:9606"},{"id":"A1766","pred":"tao:has_database_id","subj":"1766","obj":"Tax:9606"},{"id":"A1767","pred":"tao:has_database_id","subj":"1767","obj":"Tax:9606"},{"id":"A1779","pred":"tao:has_database_id","subj":"1779","obj":"MESH:C000657245"},{"id":"A1780","pred":"tao:has_database_id","subj":"1780","obj":"MESH:D029424"},{"id":"A1781","pred":"tao:has_database_id","subj":"1781","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Facility cases: among clinically suspected patients: those with a positive RT‐PCRFacility controls: clinically non‐suspected patients + suspected patients with negative RT‐PCRCountry: ChinaDates: 14 January 2020‐9 February 2020Symptoms and severity: all patients admitted, with exposure history to COVID‐19, so all levels of severity; days from illness onset until admission (median, IQR): 2.0 (1.0‐5.0); patient population with general mild disease and limited presence of comorbidities (range 0%‐2.3% (COPD))Demographics: age: controls median 40.0 years (IQR 32.5‐54.5), cases median 39.0 years (IQR 37.0‐41.5)M%/F%: cases 71.4/28.6, controls 63.2/36.8Exposure history: epidemiological history of exposure to COVID‐19 (as per WHO guidance)"}